Aktionsplan Rain Therapeutics Inc.
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen Rain Therapeutics Inc.
Rain Therapeutics Inc., компания, занимающаяся прецизионной онкологией, занимается разработкой методов лечения онкогенных факторов в Соединенных Штатах. Его ведущим кандидатом в продукт является RAIN-32, низкомолекулярный пероральный ингибитор мышиной двойной минуты 2, который является онкогенным при различных раковых заболеваниях. weitere details| IPO date | 2021-04-23 |
|---|---|
| ISIN | US75082Q1058 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.rainthera.com |
| Цена ао | 2.22 |
| Preisänderung pro Tag: | -5% (1.9061) |
|---|---|
| Preisänderung pro Woche: | -2.94% (1.8656) |
| Preisänderung pro Monat: | -32.38% (2.6778) |
| Preisänderung über 3 Monate: | +49.64% (1.21) |
| Preisänderung über sechs Monate: | +49.64% (1.21) |
| Preisänderung pro Jahr: | +49.64% (1.21) |
| Preisänderung über 3 Jahre: | -62.97% (4.89) |
| Preisänderung seit Jahresbeginn: | +49.64% (1.21) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Tang Capital Management, LLC | 3740341 | 13.56 |
| BVF Inc. | 3526729 | 12.79 |
| Samsara BioCapital, LLC | 2034552 | 7.38 |
| Boxer Capital, LLC | 1152212 | 4.18 |
| Blackrock Inc. | 1015385 | 3.68 |
| Vanguard Group Inc | 902664 | 3.27 |
| Acadian Asset Management. LLC | 609916 | 2.21 |
| Acuitas Investments LLC | 409256 | 1.48 |
| Russell Investments Group, Ltd. | 395935 | 1.44 |
| Geode Capital Management, LLC | 329216 | 1.19 |
| ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
|---|---|---|---|
| iShares MSCI India Small-Cap ETF | 0.09335 | 0.4625 | 0.96163 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.03802 | 7.67 | 2.7853 |
WisdomTree India Earnings Fund
|
0.03677 | 5.23 | 1.65591 |
| Dimensional Emerging Markets Value ETF | 0.03604 | 17.07 | 4.19508 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.035 | 5.46 | 3.03583 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.01754 | 15.96 | 3.34087 |
| PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF | 0.0105 | 2.43 | 4.35382 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.01 | 9.39 | 3.09932 |
| SPDR Portfolio Emerging Markets ETF | 0.00615 | 11.59 | 3.1879 |
| Avantis Emerging Markets Equity ETF | 0.00374 | 8.77 | 3.60513 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00333 | 13.06 | 3.62488 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.02 | 8.62 | 3.08 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Mr. Avanish Vellanki M.B.A. | Co-Founder, CEO & Chairman | 959.75k | 1975 (50 Jahre) |
| Dr. Robert C. Doebele M.D., Ph.D. | Co-Founder, Chairman of Scientific Advisory Board, President & CSO and Chief Medical Officer | 700.56k | 1971 (54 Jahr) |
| Ms. Vijaya Tirunagaru Ph.D. | Senior VP & Head of Research | N/A | |
| Mr. Erik Atkisson | General Counsel & Chief Compliance Officer | N/A | 1972 (53 Jahr) |
| Ms. Charmi Turner | Vice President of People & Culture | N/A | |
| Ms. Josephine Bruce | Principal Financial & Accounting officer | N/A | 1979 (46 Jahre) |
| Dr. Nora Ku M.D. | MD & VP of Clinical Development | N/A | |
| Ms. Theresa O'Connell M.S. | Director of Corporate Development & Operations |
Adresse: United States, Newark, CA -, 8000 Jarvis Avenue - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: http://www.rainthera.com
Webseite: http://www.rainthera.com
